Goldman Sachs’s Exelixis EXEL Stock Holding History

Goldman Sachs’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-12,600	Closed	-$285K	–	6283
2021 Q1	$285K	Buy	+12,600	New	+$285K	﹤0.01%	5453
2020 Q3	–	Sell	-30,000	Closed	-$712K	–	5377
2020 Q2	$712K	Sell	30,000 -10,000	-25%	-$232K	﹤0.01%	4173
2020 Q1	$689K	Buy	+40,000	New	+$732K	﹤0.01%	4010
2019 Q2	–	Sell	-290,000	Closed	-$6.9M	–	5188
2019 Q1	$6.9M	Buy	+290,000	New	+$6.61M	﹤0.01%	2728
2018 Q2	–	Sell	-40,000	Closed	-$886K	–	5758
2018 Q1	$886K	Sell	40,000 -50,000	-56%	-$1.38M	﹤0.01%	4130
2017 Q4	$2.74M	Buy	+90,000	New	+$2.39M	﹤0.01%	3531
2015 Q3	–	Sell	-500,000	Closed	-$1.88M	–	7334
2015 Q2	$1.88M	Buy	+500,000	New	+$1.63M	﹤0.01%	3881
2015 Q1	–	Sell	-576,600	Closed	-$830K	–	7137
2014 Q4	$830K	Hold	576,600	–	–	﹤0.01%	4783
2014 Q3	$882K	Buy	576,600 +1,800	+0.3%	+$5.78K	﹤0.01%	4738
2014 Q2	$1.95M	Sell	574,800 -65,400	-10%	-$226K	﹤0.01%	4019
2014 Q1	$2.27M	Buy	640,200 +348,000	+119%	+$2.37M	﹤0.01%	3857
2013 Q4	$1.79M	Hold	292,200	–	–	﹤0.01%	4193
2013 Q3	$1.7M	Buy	+292,200	New	+$1.51M	﹤0.01%	4075

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Goldman Sachs's EXEL Position: Q1 2026 in Review

Goldman Sachs increased its Exelixis (EXEL) stake by 0.15% in Q1 2026, buying an estimated $134K and bringing the position to 2,118,574 shares worth $90.9M. The position accounts for 0.01% of the portfolio, ranked #1092.

Goldman Sachs first reported a position in EXEL in Q2 2013 and has held it in 52 quarters since. The position peaked at $451M in Q4 2017. 695 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

Goldman Sachs held 2,118,574 shares of Exelixis worth $90.9M as of Q1 2026.
Goldman Sachs bought 3,118 Exelixis shares in Q1 2026, an estimated $134K.
Exelixis made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1092 holding.
Goldman Sachs first reported a position in Exelixis in Q2 2013 and has held it in 52 quarters since.
Goldman Sachs's Exelixis position peaked at $451M in Q4 2017.
695 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.